Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Clinical trial NCT04379050 · COMPLETED
Trial details
- NCT number
- NCT04379050
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-08
- Primary completion
- 2026-04-17
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.